3 result found:

Malignant neoplasm of prostate
ICD-10-CM Diagnosis Code C61
  • C61 Malignant neoplasm of prostate
Benign prostatic hyperplasia
benign neoplasms of prostate (adenoma, benign) (fibroadenoma) (fibroma) (myoma) (D29.1); malignant neoplasm of prostate (C61); adenofibromatous hypertrophy of prostate; benign hypertrophy of the prostate; benign prostatic hypertrophy; BPH; enlarged prostate; nodular prostate; polyp of prostate
ICD-10-CM Diagnosis Code N40
  • N40 Benign prostatic hyperplasia
    • N40.0 Benign prostatic hyperplasia without lower ur...
    • N40.1 Benign prostatic hyperplasia with lower urina...
    • N40.2 Nodular prostate without lower urinary tract ...
    • N40.3 Nodular prostate with lower urinary tract sym...
Long term (current) use of agents affecting estrogen receptors and estrogen levels
Lng trm (crnt) use of agnt aff estrog recpt & estrog levels; , if applicable:; malignant neoplasm of breast (C50.-); malignant neoplasm of prostate (C61); hormone replacement therapy (Z79.890); code, if applicable, to identify:; estrogen receptor positive status (Z17.0); family history of breast cancer (Z80.3); genetic susceptibility to malignant neoplasm (cancer) (Z15.0-); personal history of breast cancer (Z85.3); personal history of prostate cancer (Z85.46); postmenopausal status (Z78.0)
ICD-10-CM Diagnosis Code Z79.81

Long term (current) use of agents affecting estrogen receptors and estrogen levels

    2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
Code First
  • , if applicable:
  • malignant neoplasm of breast (C50.-)
  • malignant neoplasm of prostate (C61)
Type 1 Excludes
  • hormone replacement therapy (Z79.890)
Use Additional
  • code, if applicable, to identify:
  • estrogen receptor positive status (Z17.0)
  • family history of breast cancer (Z80.3)
  • genetic susceptibility to malignant neoplasm (cancer) (Z15.0-)
  • personal history of breast cancer (Z85.3)
  • personal history of prostate cancer (Z85.46)
  • postmenopausal status (Z78.0)